DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes.
about
Genetics of pancreatitisMultiple endocrine neoplasias: advances and challenges for the futurePrimary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery?Molecular genetics in primary hyperparathyroidism: the role of genetic tests in differential diagnosis, disease prevention strategy, and therapeutic planning. A 2017 update.Molecular diagnosis of parathyroid carcinoma: a reality in the near future.
P2860
DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
DNA-based test: when and why t ...... hyroidism clinical phenotypes.
@en
DNA-based test: when and why t ...... hyroidism clinical phenotypes.
@nl
type
label
DNA-based test: when and why t ...... hyroidism clinical phenotypes.
@en
DNA-based test: when and why t ...... hyroidism clinical phenotypes.
@nl
prefLabel
DNA-based test: when and why t ...... hyroidism clinical phenotypes.
@en
DNA-based test: when and why t ...... hyroidism clinical phenotypes.
@nl
P2093
P1476
DNA-based test: when and why t ...... hyroidism clinical phenotypes.
@en
P2093
P2860
P356
10.1111/J.1365-2796.2009.02105.X
P407
P577
2009-07-01T00:00:00Z